Over the past 12 months, 0 insiders at Clearside Biomedical, Inc. filed 0 open-market SEC Form 4 transactions on CLSD: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 24, 25 | Clay ThorpDirector | BUY | 15.0K | $0.92 | $14K |
| Nov 1, 24 | Chong Ngai Hang VictorChief Medical Officer | BUY | 36.5K | $1.00 | $37K |
| Jun 24, 24 | Chong Ngai Hang VictorChief Medical Officer | BUY | 23.5K | $1.06 | $25K |
| May 15, 24 | Benjamin R YerxaDirector | BUY | 7.8K | $1.31 | $10K |
| Apr 18, 24 | Anthony S GibneyDirector | BUY | 93.3K | $1.30 | $121K |
| Apr 17, 24 | Anthony S GibneyDirector | BUY | 6.7K | $1.25 | $8K |
| Mar 20, 24 | Chong Ngai Hang VictorCHIEF MEDICAL OFFICER | BUY | 30.0K | $1.60 | $48K |
| Feb 7, 24 | Bradford T WhitmoreTenPercentOwner | BUY | 444.4K | $1.35 | $600K |
| Jan 19, 24 | Charles A. DeignanChief Financial Officer | SELL | 12.9K | $1.28 | $17K |
| Jan 19, 24 | George M LasezkayCEO | SELL | 18.0K | $1.27 | $23K |
| Nov 1, 23 | Bradford T WhitmoreTenPercentOwner | BUY | 64.4K | $0.74 | $48K |
| Oct 31, 23 | Bradford T WhitmoreTenPercentOwner | BUY | 70.8K | $0.73 | $52K |
| Oct 30, 23 | Bradford T WhitmoreTenPercentOwner | BUY | 600 | $0.69 | $414 |
| Oct 3, 23 | Nancy J HutsonDirector | BUY | 10.0K | $0.86 | $9K |
| Sep 25, 23 | Clay ThorpDirector | BUY | 10.0K | $0.86 | $9K |
| Jan 20, 23 | Thomas CiullaChief Medical Officer | SELL | 13.7K | $1.47 | $20K |
| Jan 19, 23 | Charles A. DeignanChief Financial Officer | SELL | 14.0K | $1.50 | $21K |
| Jan 19, 23 | George M LasezkayCEO | SELL | 20.0K | $1.46 | $29K |
| Jan 10, 23 | Thomas CiullaChief Medical Officer | SELL | 2.2K | $1.62 | $4K |
| Dec 21, 22 | Clay ThorpDirector | BUY | 14.0K | $1.02 | $14K |
| Nov 17, 22 | Nancy J HutsonDirector | BUY | 30.0K | $1.33 | $40K |
| Jan 19, 22 | Thomas CiullaChief Medical Officer | SELL | 9.1K | $2.13 | $19K |
| Jan 19, 22 | Charles A. DeignanChief Financial Officer | SELL | 8.8K | $2.09 | $18K |
| Jan 19, 22 | George M LasezkayCEO | SELL | 10.8K | $2.12 | $23K |
| Jan 11, 22 | George M LasezkayCEO | SELL | 5.1K | $2.46 | $13K |
| Sep 21, 21 | Thomas CiullaChief Medical Officer | SELL | 2.6K | $6.40 | $16K |
| Sep 21, 21 | Charles A. DeignanChief Financial Officer | SELL | 2.8K | $6.41 | $18K |
| Sep 21, 21 | George M LasezkayCEO | SELL | 3.5K | $6.46 | $23K |
| Sep 1, 21 | Bradford T WhitmoreTenPercentOwner | SELL | 213.2K | $6.89 | $1.5M |
| Aug 31, 21 | Bradford T WhitmoreTenPercentOwner | SELL | 107.7K | $6.96 | $749K |
| Aug 30, 21 | Bradford T WhitmoreTenPercentOwner | SELL | 99.4K | $7.06 | $702K |
| Aug 16, 21 | Nancy J HutsonDirector | BUY | 3.0K | $5.68 | $17K |
Over the past 12 months, insiders at Clearside Biomedical, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on CLSD, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market CLSD insider purchase in our data was $600K by Bradford T Whitmore, TenPercentOwner, filed on Feb 7, 24.
0 different insiders at Clearside Biomedical, Inc. filed open-market SEC Form 4 transactions on CLSD over the last 12 months.
InsiderTape plots every CLSD insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Clearside Biomedical, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →